Sunday October 25, 2020

Naming the price: Ireland's pharmaceutical companies

The decision to force pharma companies to disclose their corporate identities was aimed at improving transparency, but has become a logistical nightmare

Ian Guider

Markets Editor

28th May, 2017
For some pharma firms, compliance would require every leaflet in every medicine pack to be updated Inset: Mary Mitchell O'Connor Picture: Maura Hickey

What’s in a name? For some of the country’s biggest pharmaceutical employers, tens of millions of euro – and even the continued supply of vital medicines – are at stake.

As part of sweeping changes to update Irish company law in 2014, much of which was designed to eliminate very old red tape, it was decided that all firms would have to publicly disclose their full corporate identity.

This means that their...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader



Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.



€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.




90 Day Pass

You can cancel any time.

2 Yearly



Unlimited Access for 2 Years

This product does not auto-renew

Team Pass

Get a Business Account for you and your team

Related Stories

The way we did business a few months ago may never return – so the opportunity is to make changes that will both aid recovery and set us up well for our new futures

Tom Maguire | 5 months ago

What’s coming up today and what you might have missed

Hannah O’Brien | 10 months ago